Common Names: dwarf lilyturf
Chinese medicine DZSMC may treat HFpEF effectively. Research on its mechanism is growing. Potential safe and effective treatment worth exploring further for high mortality condition.
Ginseng and Ophiopogonin, traditional Chinese herbal pair, enhance immune system in cancer patients. Study identifies main active components and their therapeutic effect on lung cancer.
The study analyzed breast cancer patients' clinical data after surgery and found that liver depression and spleen deficiency syndrome was common. Common TCM combinations were identified, aiding prescription decision-making post-surgery.
YQFM, a Chinese treatment for heart diseases, shows potential in alleviating sepsis-induced cardiomyopathy (SIC) by reducing iron overload and lipid peroxidation and activating the xCT/GPX4 axis, which may help in preventing or treating SIC.
Mai Men Dong decoction (MMDD), a traditional Chinese medicine, contains herbs known for treating respiratory conditions. Studying MMDD can enhance understanding and development of ethnopharmacology.
Ruscogenin, extracted from Ophiopogon japonicus, has shown potential in reducing cerebral ischemia-reperfusion injury and acute lung injury. However, its chronopharmacological effects have yet to be determined.
This study examined the effects of Ophiopogonin D (OP-D) on non-alcoholic fatty liver disease (NAFLD) in mice. OP-D was found to improve NAFLD by regulating lipid metabolism, antioxidant, and anti-inflammatory responses. OP-D also reduced lipogenesis and inflammation, potentially through the NF-κB signaling pathway.
Researchers investigated the molecular mechanism behind the popular herbal medicine Dengzhan shengmai (DZSM) formula, which is commonly used to aid recovery from ischemic cerebrovascular diseases. The formula is composed of four herbal medicines and the study found that it promotes angiogenesis, which improves blood flow and aids in the recovery process. The study provides valuable insight into the potential benefits of traditional herbal medicines in treating vascular diseases.
Ruscogenin, a sapogenin from Ophiopogon japonicus, has been shown to protect against ischemic injury to the brain. Researchers investigated its effects on blood-brain barrier dysfunction after stroke and found that it decreased brain damage, improved neurological function, and increased blood flow in mice. In brain cells, ruscogenin increased cell viability, decreased leakage, and modulated tight junction expression. It also inhibited the expression of inflammatory markers and decreased reactive oxygen species generation. These findings suggest that ruscogenin has potential for preventing and treating stroke.